Factor Xa inhibitors are a type of anticoagulant that work by selectively and reversibly blocking the activity of clotting factor Xa, preventing clot formation. They affect both factor Xa within the blood and within a preexisting clot. They do not affect platelet aggregation. They are used for the treatment and prevention of deep vein thrombosis and acute pulmonary embolism, and to reduce the risk of stroke and embolism in people with nonvalvular atrial fibrillation.
Factor Xa is generated by both the extrinsic and intrinsic coagulation pathways and is responsible for activating prothrombin to thrombin. Factor Xa inhibitors have predictable anticoagulant effects and do not require routine monitoring, unlike some other anticoagulants.
Apixaban, edoxaban, fondaparinux, and rivaroxaban are all Factor Xa inhibitors.
Data
Source:drugs.com
Eliquis
ELIQUIS is a prescription medication used to reduce the risk of stroke and blood clots in people with certain heart conditions. It belongs to a class of drugs called anticoagulants, which work by preventing the formation of blood clots. ELIQUIS is typically taken orally, and its effectiveness is monitored through regular blood tests. It is important to follow the prescribed dosage and consult with a healthcare professional before starting or stopping this medication.
Fondaparinux is a medication used to prevent blood clots in patients who are at risk for deep vein thrombosis or pulmonary embolism. It is an anticoagulant that works by inhibiting the activity of certain clotting factors in the blood. Fondaparinux is typically administered as a subcutaneous injection and is commonly prescribed for patients undergoing surgery or those with certain medical conditions that increase their risk of blood clots.
SAVAYSA is a medication used to prevent blood clots in individuals with certain medical conditions. It belongs to a class of drugs called direct oral anticoagulants and works by inhibiting a specific clotting factor in the blood. SAVAYSA is typically prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as to prevent deep vein thrombosis and pulmonary embolism in individuals who have undergone hip or knee replacement surgery. It is taken orally once daily and should be used as directed by a healthcare professional.
XARELTO is a prescription medication used to prevent blood clots and reduce the risk of stroke in patients with certain medical conditions. It belongs to a class of drugs called anticoagulants, which work by inhibiting the clotting process in the blood. XARELTO is commonly prescribed for individuals with atrial fibrillation, deep vein thrombosis, or pulmonary embolism. It is taken orally and is available in tablet form. As with any medication, XARELTO may have potential side effects and should be used under the guidance of a healthcare professional.
